EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

HLA polymorphisms in South Tunisian systemic sclerosis patients: a case-control study

Aida Charfi, Raida Ben Salah, Olfa Frikha, Nadia Mahfoudh, Arwa Kamoun, Yosra Bouattour, Lilia Gaddour, Feiza Hakim, Zouhir Bahloul, Hafedh Makni

Clinical Rheumatology · 2025

DOI: 10.1007/s10067-025-07679-3 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Aida Charfi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Histocompatibility Department, Hedi Chaker UH, University of Sfax, Sfax, Tunisia. Hauptthemen laut MEDLINE: Scleroderma, Systemic, HLA-DRB1 Chains, HLA-DQ beta-Chains, Polymorphism, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Systemic sclerosis (SSc) is a complex autoimmune connective tissue disease. Genetic factors may play a pivotal role in determining susceptibility to these disorders. HLA associations with SSc, especially HLA class II, were investigated in different populations but not in Tunisia. Our aim was to study HLA profile in South Tunisian patients with SSc. METHODS: We conducted a case-control study on 19 SSc patients and 123 healthy controls. HLA class I (HLA-A and -B) typing was performed using a microlymphocytotoxicity complement-dependent technique followed by polymerase chain reaction sequence specific primer (PCR-SSP). HLA class II DRB1/DQB1 of all patients and controls was genotyped using the PCR-SSP technique. Statistical analysis was performed using SPSS software and R language. RESULTS: Nineteen SSc patients and 123 healthy controls were included. The HLA-DRB1*11 was associated with the genetic susceptibility to SSc (corrected p-value (pc) = 0.005; OR = 5.56; 95% CI = [2-15.4]). The HLA-DQB1*03:01 had also increased the risk of SSc in our study (pc = 0.002; OR = 5.9; 95% CI = [2-16.8]). Concerning HLA class I typing, we found a significant association between HLA-B53 and SSc (pc = 0.01; OR = 9; 95% CI = [2.53-31.99]). The association of HLA-B53 was independent of HLA-DRB1*11 in binary logistic regression test (HLA-B53: p = 0.01; HLA-DRB1*11: p = 0.008). Concerning the haplotype study, a significant difference in the distribution of the haplotype B53-DRB1*11 was found between patients and controls (13.15% in SSc patients vs. 0.8% in controls; p = 1.33 10-5; HaploScore = 4.35). CONCLUSION: Our results showed that in South Tunisia SSc is associated with HLA-DRB1*11 and DQB1*03:01 alleles. A susceptibility to SSc was found in positive HLA-B53 patients. This association of HLA alleles with SSc needs further study. Key Points •HLA-DR and DQ alleles represent the most common associations reported in Systemic Sclerosis (SSc). •In this study, in addition to the known association with HLA-DRB1*11, we identified an association with HLA-B53 in a cohort of 19 South Tunisian patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicHLA-DRB1 ChainsHLA-DQ beta-ChainsPolymorphism, GeneticHumansTunisiaCase-Control StudiesFemaleMaleGenetic Predisposition to DiseaseMiddle AgedAdultGenotypeAgedGene FrequencyAllelesHaplotypes

Stichwörter der Autor:innen

Diffuse systemic sclerosisDisease susceptibilityHLALimited systemic sclerosisSystemic sclerosis

Substanzen

HLA-DRB1 ChainsHLA-DQ beta-ChainsHLA-DQB1 antigen

Autor:innen und Institutionen

  • Histocompatibility Department, Hedi Chaker UH, University of Sfax, Sfax, Tunisia.
  • Department of Internal Medicine, Hedi Chaker UH, University of Sfax, Sfax, Tunisia. raidabensalah@yahoo.fr.
  • Department of Internal Medicine, Hedi Chaker UH, University of Sfax, Sfax, Tunisia.

Zitieren

APA

Charfi, A., Salah, R. B., Frikha, O., Mahfoudh, N., Kamoun, A., Bouattour, Y., Gaddour, L., Hakim, F., Bahloul, Z., & Makni, H. (2025). HLA polymorphisms in South Tunisian systemic sclerosis patients: a case-control study. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07679-3

Vancouver

Charfi A, Salah RB, Frikha O, Mahfoudh N, Kamoun A, Bouattour Y, et al. HLA polymorphisms in South Tunisian systemic sclerosis patients: a case-control study. Clinical Rheumatology. 2025. doi:10.1007/s10067-025-07679-3

BibTeX
@article{Charfi2025,
  author = {Charfi, Aida and Salah, Raida Ben and Frikha, Olfa and Mahfoudh, Nadia and Kamoun, Arwa and Bouattour, Yosra and Gaddour, Lilia and Hakim, Feiza and Bahloul, Zouhir and Makni, Hafedh},
  title = {HLA polymorphisms in South Tunisian systemic sclerosis patients: a case-control study},
  journal = {Clinical Rheumatology},
  year = {2025},
  doi = {10.1007/s10067-025-07679-3}
}
Kostenlos starten →